Jill broussard 0111219 37 Sarah Emma Kate Prch 2659 V1 layers

MiSight® 1 day

Myopia management starts 1 day at a time

More than 40% of Americans are myopic – and that number is increasing at an alarming rate, especially among school-age children.* Fortunately, there’s a treatment that can help: MiSight® 1 day is the first and only soft contact lens FDA-approved** to slow the progression of myopia in children, aged 8-12 at initiation of treatment.1

Multinational study: What we learned

CooperVision® undertook a rigorous, multi-year, multi-country study to track how the MiSight® 1 day contact lens affected myopia progression in children aged 8-12 at the initiation of treatment.1† After three years, the study concluded the lens effectively slowed myopia progression by 59% and slowed the rate at which the eye lengthens by 52% compared to children in the control group wearing a single-vision 1-day lens.2

A revolutionary treatment

MiSight® is an FDA-approved** lens available as part of a comprehensive myopia management approach offered by CooperVision® and participating Vision Source® practices. The ActivControlTM Technology in MiSight® 1 day utilizes an optic zone concentric ring design with alternating vision correction and treatment zones. The design allows the child to see clearly while benefitting from the treatment effect.

Resources to build your practice

Check out CooperVision®'s new waiting room video featuring MiSight® 1 day spokesperson and wearer Alan Kim below, and download the video for your own use in the further insights section to the right. Kim has myopia and shares his MiSight® 1 day experience, demonstrating how he can wear contact lenses successfully at his age and enjoy the benefits of increased confidence and freedom in everyday activities.

Further Insight

* Cooper, Y. (2019, May 1). With Childhood Myopia Rates on the Rise, the American Optometric Association Highlights the Importance of Early Intervention through Annual Eye Exams. Retrieved from https://www.aoa.org/newsroom/m...

** Indications for Use: MiSight® (omafilcon A) daily wear single use Soft Contact Lenses are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

† Compared to a single vision 1 day lens over a 3 year period.


1 Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8): 556-567.

2 CooperVision data on file 2019. How much do you like wearing your contact lenses? 87/97 (90%) Top box ‘I like contact lenses the best’ Subjective response @60M.

CooperVision logo Vision source logo

© 2024 CooperVision | Part of CooperCompanies | Privacy policy | California Privacy policy | Terms of service